Drug Target Review – Issue 2 2021
Posted: 14 June 2021 | Drug Target Review | No comments yet
This issue includes articles on novel AAV vectors to deliver ocular gene therapy, how phenotypic models of disease are being used in covalent fragment screening and the challenges and opportunities presented by automation in the life sciences. Also in this issue are features on stem cells, antibodies and hit-to-lead.
Included in this issue:
- GENOMICS
The potential of epigenomic medicine in cardiology
Professor John Giannios, Learna - CELL & GENE THERAPY
Using cholangiocyte organoids to regenerate human bile ducts
Dr Fotios Sampaziotis, University of Cambridge - CELL LINE DEVELOPMENT
Making cell culture models more physiologically relevant
Robert Skolik, University of Louisville - STEM CELLS
Transcriptional reprogramming rescues vascular fate of misidentified pluripotent cell-derived epithelial cells
Dr Raphaël Lis, Weill Cornell Medicine - SCREENING
Screening for COVID-19 drugs
Professor Arvind Patel, Medical Research Council-University of Glasgow Centre for Virus Research (CVR) - ANTIBODIES
How to mix the best anti-SARS-CoV-2 cocktail
Dr Zhiqiang Ku, University of Texas Health Science Center at Houston
The rest of this content is restricted - login or subscribe free to access
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- quarterly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
Related topics
Antibodies, Biologics, Cell culture, Drug Development, Gene Therapy, Genomics, Hit-to-Lead, Lab Automation, Screening, Stem Cells